-
公开(公告)号:CY1110934T1
公开(公告)日:2015-06-10
申请号:CY101101044
申请日:2010-11-19
Applicant: ABBOTT LAB
Inventor: WAYNE GREG S , MELLICAN SEAN M , ZHANG GEOFF G , WILLCOX DAVID R , BRETING JEFFREY M
IPC: C07D487/04
Abstract: Ηπαρούσαεφεύρεσησχετίζεταιμετοάλας (1S,5S)-3-(5,6-διχλωροπυριδιν-3-υλ)-3,6-διαζαδικυκλο [3.2.0]επτάνιοβενζολοσουλφονικόκαιμεμεθόδουςπαραγωγήςτουάλατος.
-
公开(公告)号:CA2582954C
公开(公告)日:2014-07-29
申请号:CA2582954
申请日:2005-10-07
Applicant: ABBOTT LAB
Inventor: ZHANG GEOFF G , BRADLEY MICHAEL F , BARNES DAVID M , HENRY RODGER
IPC: C07D401/14
Abstract: A crystalline form of 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylic acid, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
-
公开(公告)号:NZ595275A
公开(公告)日:2013-07-26
申请号:NZ59527507
申请日:2007-02-16
Applicant: ABBOTT LAB
Inventor: ZHENG GUO ZHU , GREGG ROBERT J , ZHANG GEOFF G
IPC: C07D487/04 , A61K31/407 , A61K31/501 , C07D237/14
Abstract: Abstract - 595275 Disclosed is a process of preparing compounds of formula (IV), wherein R1 is an alkyl group and Cy1a is aryl or heteroaryl, comprising the step of treating a compound of formula (III) with alkylating conditions to provide a compound of formula (IV). Also disclosed is a process for preparing a compound of formula (IV), wherein R1 is an alkyl group, and Cy1 is aryl, comprising the steps of: a) providing ethyl (3aR,6aR)-hexahydropyrrolo[2,3-c]pyrrole-5(1H)-carboxylate dibenzoyl-D-tartrate salt; b) treating ethyl (3aR,6aR)-hexahydropyrrolo[2,3-c]pyrrole-5(1H)-carboxylate dibenzoyl-D-tartrate salt with a base to yield a compound of formula (IIIa); c) heating the compound of formula (IIIa), wherein P is ethoxycarbonyl and a compound of formula (IIIb), with a carbonate base, a palladium source, and Xantphos in a solvent, to provide a compound of formula (IIIc); d) heating the compound of formula (IIIc) with a compound of formula (IIId), a carbonate base and a copper source in a high-boiling polar solvent (such as dimethylformamide (DMF), dimethylacetamide (DMA), pyridine, or 4-methylpyridine) to provide a compound of formula (IIIe); e) removing the ethoxycarbonyl group to provide a compound of formula (III), and alkylating the compound of formula (III) to provide a compound of formula (IV), wherein the compound of formula (IV) is a compound such as 2-{ 4'-[(3aR,6aR)-5-methylhexahydropyrrolo[3,4-b]pyrrol-1(2H)-yl]-1,1'-biphenyl-4-yl} pyridazin-3(2H)one.
-
公开(公告)号:CA2574896C
公开(公告)日:2012-01-03
申请号:CA2574896
申请日:2005-07-08
Applicant: ABBOTT LAB
Inventor: WAYNE GREG S , MELLICAN SEAN M , ZHANG GEOFF G , WILLCOX DAVID R , BRETING JEFFREY M
IPC: C07D487/04
Abstract: The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate and to methods of preparing the salt.
-
公开(公告)号:BRPI0708258A2
公开(公告)日:2011-05-24
申请号:BRPI0708258
申请日:2007-02-16
Applicant: ABBOTT LAB
Inventor: COWART MARLON D , ZHAO CHEN , SUN MINGHUA , BLACK LAWRENCE A , ZHENG GUO ZHU , GREGG ROBERT J , ZHANG GEOFF G , SHEIKH AHMAD Y , LOU XIAOCHUN , HENRY RODGER F , BARNES DAVID M , KOLACZKOWSKI LAWRENCE , HAIGHT ANTHONY R , CHANG SOU-JEN , WITTENBERGER STEVEN J , FICKES MICHAEL G
IPC: C07D487/04 , A61K31/407
Abstract: Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.
-
公开(公告)号:ZA200903093B
公开(公告)日:2010-01-27
申请号:ZA200903093
申请日:2009-05-05
Applicant: ABBOTT LAB
Inventor: BRETING JEFFREY M , MELLICAN SEAN M , WAYNE GREG S , WILLCOX DAVID R , ZHANG GEOFF G
IPC: C07D20100101
Abstract: The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate and to methods of preparing the salt.
-
公开(公告)号:BRPI0513719A
公开(公告)日:2008-05-13
申请号:BRPI0513719
申请日:2005-07-08
Applicant: ABBOTT LAB
Inventor: BUCKLEY MICHAEL J , JI JIANGUO , ZHANG GEOFF G , HENRY RODGER F , WANG WEILI W , WAYNE GREG S , LI WENKE , TOWNE TIMOTHY B , WITTENBERGER STEVEN J , HANNICK STEVEN M , KOTECKI BRIAN J , MARCI BRYAN S , ROBBINS TIMOTHY A
IPC: C07D487/04 , A61K31/4439
Abstract: The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic acetylcholine receptor.
-
公开(公告)号:ZA201303586B
公开(公告)日:2015-01-28
申请号:ZA201303586
申请日:2013-05-16
Applicant: ABBOTT LAB
Inventor: CATRON NATHANIEL D , GONG YUCHUAN , CHEN SHUANG , ZHANG GEOFF G
IPC: A61K20060101 , A61P20060101 , C07D20060101
Abstract: Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
-
29.
公开(公告)号:PT1771451E
公开(公告)日:2010-11-10
申请号:PT05770762
申请日:2005-07-08
Applicant: ABBOTT LAB
Inventor: WAYNE GREG S , MELLICAN SEAN M , ZHANG GEOFF G , WILLCOX DAVID R , BRETING JEFFREY M
IPC: C07D487/04
-
公开(公告)号:DE602005023467D1
公开(公告)日:2010-10-21
申请号:DE602005023467
申请日:2005-07-08
Applicant: ABBOTT LAB
Inventor: WAYNE GREG S , MELLICAN SEAN M , ZHANG GEOFF G , WILLCOX DAVID R , BRETING JEFFREY M
IPC: C07D487/04
-
-
-
-
-
-
-
-
-